Conexio Overview
- Founded
-
2002

- Status
-
Acquired/Merged
- Employees
-
11

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Conexio General Information
Description
Developer of genetic sequencing and mutation detection products and services. The company has developed and supplied a novel genetic sequencing and mutation detection products and specializes in typing used to match patients and donors for bone marrow or cord blood transplants.
Contact Information
Website
www.conexio-genomics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- PO BOX 1294
- Fremantle, Western Australia 6959
- Australia
Conexio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Conexio Patents
Conexio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3080302-B1 | Methods and probes for identifying gene alleles | Active | 10-Dec-2013 | 0000000000 | |
JP-2022116047-A | Methods and probes for identifying gene alleles | Pending | 10-Dec-2013 | 0000000000 | |
US-20160312281-A1 | Methods and probes for identifying gene alleles | Inactive | 10-Dec-2013 | 0000000000 | |
US-20210147935-A1 | Methods and probes for identifying gene alleles | Pending | 10-Dec-2013 | 0000000000 | 0 |
AU-2014361730-A1 | Methods and probes for identifying gene alleles | Active | 10-Dec-2013 | C12Q1/6881 |
Conexio Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
David Sayer Ph.D | Co-Founder & Chief Executive Officer | ||
Damian Goodridge Ph.D | Co-Founder, Chief Software Engineer & Lead Software Developer |
Conexio Signals
Conexio Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|